GlassScriptPhysician profile
David G Nelson
NPI 1396752259
$6,784.32
in general payments reported to CMS, 2019-2025
44 companies · $377 in 2025
The $377 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $585 · 2020: $919 · 2021: $1,074 · 2022: $1,229 · 2023: $1,485 · 2024: $1,116 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,977.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,977.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $996.45 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $776.68 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $615.95 | 2019-2024 | Farxiga, Airsupra |
| Pfizer INC. | $476.50 | 2019-2025 | |
| Glaxosmithkline, LLC. | $409.60 | 2020-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $400.11 | 2019-2024 | Xifaxan |
| Lilly USA, LLC | $320.00 | 2019-2024 | Mounjaro, Jardiance, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $319.90 | 2021-2025 | |
| Astellas Pharma US INC | $315.95 | 2019-2025 | Veozah |
| Amarin Pharma, INC. | $224.40 | 2020-2023 | |
| Davol INC. | $152.20 | 2023 | Progel Applicator Spray Tips |
| Takeda Pharmaceuticals U.S.A., INC. | $151.77 | 2019-2022 | |
| Corium, LLC | $143.01 | 2022-2023 | Azstarys |
| Medtronic, INC. | $122.63 | 2022 | |
| Gilead Sciences, INC. | $112.40 | 2019-2021 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.